Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
SODIUM PYRROLIDONE CARBOXYLATE
Alliance Pharmaceuticals Ltd.
D02AX
SODIUM PYRROLIDONE CARBOXYLATE
2.5 %w/w
Cream
Product not subject to medical prescription
Other emollients and protectives
Not marketed
2006-08-11
A A r r t t w w o o r r k k I I n n f f o o r r m m a a t t i i o o n n Magenta text, keylines and shading are NOT to be printed Product Title: Hydromol Cream leaflet Date: 12-05-15 Product Size: 126mm x 150mm Label Number: 15-048 Version 3 Colours Used: PMS 291, PMS 292, PMS 274 Fonts Used: Swiss 721, Palatino Font size (min): 6.5pt XXXXX © Alliance Pharmaceuticals Limited. 2015 Hydromol cream is manufactured by: Dales Pharmaceuticals Limited, Skipton, North Yorkshire, BD23 2RW, UK. The active ingredient in this medicine is sodium pyrrolidone carboxylate 2.5%. The other ingredients are liquid paraffin, isopropyl myristate, sodium lactate solution, cetomacrogol emulsifying wax, myristyl myristate, macrogol cetostearyl ether, hydroxybenzoates (parabens) (E218, E214, E216), phenoxyethanol and purified water. THIS LEAFLET WAS LAST REVISED: April 2015. Alliance Pharmaceuticals Limited. Hydromol is a registered trade mark of Alliance Pharmaceuticals Limited. The product licence holder is: Alliance Pharmaceuticals Limited, C R E A M Sodium Pyrrolidone Carboxylate REPORTING OF SIDE EFFECTS If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmaccovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. If your condition worsens consult your doctor or pharmacist. Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Sodium pyrrolidone carboxylate 2.5 % w/w Cream 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Sodium Pyrrolidone Carboxylate 2.50 % w/w. Excipients: Contains cetostearyl alcohol 4%w/w. Contains hydroxybenzoates (parabens) approximately 1%w/w: methyl (E218), ethyl (E214), propyl (E216) and butyl parahydroxybenzoates. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Cream Soft, white oil-in-water cream. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As a lubricant and hydrating agent in the management of dry skin conditions such as certain types of eczema, ichthyosis and senile pruritus. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Route of administration For topical use only. ADULTS, CHILDREN AND THE ELDERLY: Apply liberally to the affected area and massage well into the skin. Sodium pyrrolidone carboxylate 2.5 % w/w Cream may be used as often as required. Sodium pyrrolidone carboxylate 2.5 % w/w Cream is especially beneficial when used immediately after washing or bathing, when the resultant warmth of the skin enhances absorption. 4.3 CONTRAINDICATIONS There are no contraindications except true hypersensitivity to any of the ingredients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE If there is aggravation of the condition consult the doctor. The formulation is not designed for use as a diluent. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _9_ _/_ _0_ _9_ _/_ _2_ _0_ _1_ _6_ _C_ _R_ _N_ _ _ _ Read the complete document